ClinicalTrials.gg
Not yet recruitingNCT07500389Updated Apr 7, 2026

Postural Habits, Body Awareness, and Functional Performance Across BMI Categories in Women

An observational study in Obesity & Overweight, Body Mass Index and Postural Control, sponsored by Ondokuz Mayıs University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-07.

Sponsored by Ondokuz Mayıs University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
80
Ages
18 Years to 65 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Obesity by Ondokuz Mayıs University — 4 open to participants now, 4 under way, none of them phase 3. Obesity · Ondokuz Mayıs University.

Started
2026
with 1 other
Observational
3 of 10
2 open now
Registered
9th of 10
by date

Among the 10 studies in Obesity by Ondokuz Mayıs University, this one is one of 2 that started in 2026, is one of 3 observational ones, and was the 9th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

4 of the 10 studies in Obesity by Ondokuz Mayıs University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 65 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Obesity by Ondokuz Mayıs University, or all of them as a file.
02

Study summary

This cross-sectional study aims to investigate the relationship between postural habits and body awareness with functional performance across different body mass index (BMI) categories in women. Participants will be categorized into four groups based on BMI (normal weight, overweight, obesity class I, and obesity class II-III). Postural habits and awareness, body awareness, and functional performance will be assessed using validated questionnaires and performance-based tests. The study also aims to explore the potential contribution of central adiposity (waist circumference) and psychological factors to these relationships. Findings are expected to provide a more comprehensive understanding of the biomechanical and perceptual factors associated with obesity.

Read the detailed description

Obesity is a growing global public health concern that affects not only metabolic and cardiovascular systems but also musculoskeletal health, postural control, and proprioceptive mechanisms. Increased body mass and altered fat distribution, particularly abdominal adiposity, may lead to biomechanical changes such as anterior shift of the center of mass, altered load distribution, and increased stress on the lower extremities. These changes may negatively influence functional performance and postural organization.

Body awareness is a multidimensional construct involving the perception, interpretation, and regulation of internal bodily sensations, while postural habits reflect behavioral patterns related to body alignment in daily activities. Although previous studies have examined body awareness and functional performance in individuals with obesity, findings regarding their interrelationships remain inconsistent. Additionally, the combined evaluation of postural habits, body awareness, and functional performance across BMI categories is limited in the literature.

This study is designed as a cross-sectional, comparative investigation including women aged 18-65 years. Participants will be classified into four BMI categories according to World Health Organization criteria. Postural habits and awareness will be assessed using the Posture Habits and Awareness Scale (PHAS), and body awareness will be evaluated using the Body Awareness Questionnaire (BAQ). Functional performance will be measured using the Timed Up and Go (TUG) test and the Five Times Sit-to-Stand (5×STS) test. A composite functional performance index will be created using standardized scores of these tests.

Anthropometric measurements including BMI and waist circumference will be obtained to assess general and central obesity. Additional variables such as physical activity level and psychological status (anxiety and depression) will also be evaluated.

The primary objective is to examine whether postural habits and body awareness differ across BMI categories and how these variables are associated with functional performance. Furthermore, the study aims to determine whether central adiposity contributes independently to these relationships when controlling for functional performance and psychological factors.

It is hypothesized that higher BMI levels will be associated with altered postural habits and body awareness, and that decreased functional performance will play a mediating role in these relationships. Additionally, waist circumference is expected to have an independent effect on postural and perceptual parameters.

03

Conditions studied

  • Obesity & Overweight
  • Body Mass Index
  • Postural Control
  • Body Awareness
  • Functional Performance

Keywords

  • Postural habits
  • body awareness
  • Functional mobility
  • Physical activity
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population will consist of women aged 18-65 years recruited from the general community. Participants will be categorized into four groups based on body mass index (BMI): normal weight, overweight, obesity class I, and obesity class II-III.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female individuals aged 18-65 years
  • Classified into categories (normal weight, overweight, obesity class I, obesity class II-III)
  • No obesity-related medical or surgical treatment in the last 6 months
  • Able to understand instructions and complete questionnaires

Exclusion criteria

Exclusion Criteria:

  • Neurological disorders affecting mobility (e.g., stroke, Parkinson's disease, multiple sclerosis, peripheral neuropathy)
  • Rheumatologic or inflammatory diseases (e.g., rheumatoid arthritis, ankylosing spondylitis)
  • Severe orthopedic conditions limiting mobility (e.g., advanced osteoarthritis)
  • Major surgery within the last 12 months affecting mobility or physical performance
  • Pregnancy
  • Acute musculoskeletal injury within the last 4 weeks
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • Normal Weight

    Women aged 18-65 years with a body mass index (BMI) between 18.5 and 24.9 kg/m². Participants in this group represent the normal weight category and will be evaluated for postural habits, body awareness, and functional performance.

    Other: Observational Assessment

  • Overweight

    Women aged 18-65 years with a BMI between 25.0 and 29.9 kg/m². This group includes participants classified as overweight and will undergo the same assessments as other groups

    Other: Observational Assessment

  • Obesity Class I

    Women aged 18-65 years with a BMI between 30.0 and 34.9 kg/m². Participants in this group represent obesity class I and will be assessed for postural habits, body awareness, and functional performance.

    Other: Observational Assessment

  • Obesity Class II-III

    Women aged 18-65 years with a BMI of 35.0 kg/m² or higher. This group includes participants with higher levels of obesity and will undergo the same evaluation protocol.

    Other: Observational Assessment

Interventions

  • OtherObservational Assessment

    Participants will undergo a comprehensive observational assessment including anthropometric measurements, self-reported questionnaires, and performance-based functional tests. Body mass index and waist circumference will be measured to classify participants into BMI categories. Postural habits and awareness will be evaluated using the Posture Habits and Awareness Scale (PHAS), and body awareness will be assessed the Body Awareness Questionnaire (BAQ). Functional performance will be measured using the Timed Up and Go (TUG) test and the Five Times Sit-to-Stand (5×STS) test. No therapeutic or experimental intervention will be applied.

06

What researchers measure

Primary outcomes

  1. Postural Habits and Awareness Level (PHAS Score)

    Postural habits and awareness will be assessed using the Postural Habits and Awareness Scale (PHAS), a validated self-reported questionnaire. The total score ranges from 21 to 105, with higher scores indicating better postural habits and greater awareness. The primary outcome will be the total PHAS score and its comparison across body mass index (BMI) categories, as well as its association with functional performance.

    Time frame: Baseline

Secondary outcomes

  1. Body Awareness Level (BAQ Score)

    Body awareness will be assessed using the Body Awareness Questionnaire (BAQ), a validated self-reported instrument measuring sensitivity to normal bodily processes. The total score ranges from 18 to 126, with higher scores indicating greater body awareness. The BAQ score will be analyzed across BMI categories and in relation to postural habits and functional performance.

    Time frame: Baseline

  2. Functional Mobility (Timed Up and Go Test)

    Functional mobility and dynamic balance will be evaluated using the Timed Up and Go (TUG) Test. The time required to stand up from a chair, walk 3 meters, turn, return, and sit down will be recorded in seconds. Scores range from 0 to an upper limit depending on performance, with lower times indicating better functional mobility and balance.

    Time frame: baseline

  3. Lower Extremity Functional Strength (5 Times Sit-to-Stand Test)

    Lower extremity functional strength will be assessed using the Five Times Sit-to-Stand Test (5×STS). The time required to complete five repetitions of sit-to-stand will be recorded in seconds. Scores range from 0 to an upper limit depending on performance, with lower times indicating better functional performance.

    Time frame: Baseline

  4. Composite Functional Performance Index

    A composite functional performance index will be calculated by converting Timed Up and Go Test and Five Times Sit-to-Stand Test results into z-scores and averaging them. The index has no fixed minimum or maximum value, as it is derived from standardized scores. Higher scores indicate poorer functional performance. This index will be used to examine associations with postural habits, body awareness, and BMI categories.

    Time frame: Baseline

  5. Waist Circumference (Central Obesity Indicator)

    Waist circumference will be measured using standardized procedures to assess central adiposity. Values will be recorded in centimeters. There is no fixed minimum or maximum value, and higher values indicate greater central obesity. This measure will be analyzed as a continuous variable and as an indicator of central obesity in relation to postural habits, body awareness, and functional performance.

    Time frame: Baseline

  6. Physical Activity Level (IPAQ-SF)

    Physical activity level will be assessed using the International Physical Activity Questionnaire - Short Form (IPAQ-SF). Total physical activity will be calculated as MET-minutes per week. Scores theoretically range from 0 to very high values depending on activity level, with higher scores indicating greater physical activity.

    Time frame: Baseline

  7. Psychological Status (HADS Score)

    Anxiety and depression levels will be assessed using the Hospital Anxiety and Depression Scale (HADS). The scale consists of two subscales: anxiety (HADS-A) and depression (HADS-D), each ranging from 0 to 21. Higher scores indicate greater symptom severity (worse psychological status). These variables will be considered in relation to primary and secondary outcomes.

    Time frame: Baseline

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — The individual participant data will not be shared due to privacy concerns and restrictions in the informed consent provided by participants

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Apr 2026; primary completion for Aug 2026, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 24, 2026
First posted
Mar 30, 2026
StartEst.
Apr 30, 2026
Primary completionEst.
Aug 1, 2026
CompletionEst.
Dec 1, 2026
Last update
Apr 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07500389
Responsible party
MİNE PEKESEN KURTÇA (Principal Investigator, Ondokuz Mayıs University) — Principal investigator
First posted
Mar 30, 2026
Start date
Apr 30, 2026 (estimated)
Primary completion
Aug 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Apr 7, 2026

Study contacts

Mine PEKESEN KURTÇA P PEKESEN KURTÇA, PhD
Contact
mine.pekesenkurtca@omu.edu.tr
+903623121919

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion